Cargando…
Mesenchymal stromal cells: main factor or helper in regenerative medicine?
Mesenchymal stromal cells (mSCs) are presently studied for the prophylaxis and therapy of a variety of diseases such as acute graft-versus-host disease after allogeneic stem cell transplantation, cardiac indications, bone degeneration, Crohn's disease, and organ rejection, as well as prevention...
Autores principales: | Zander, Axel R, Lange, Claudia, Westenfelder, Christof |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089635/ https://www.ncbi.nlm.nih.gov/pubmed/25018905 http://dx.doi.org/10.1038/kisup.2011.17 |
Ejemplares similares
-
Protective actions of administered mesenchymal stem cells in acute kidney injury: relevance to clinical trials
por: Westenfelder, Christof, et al.
Publicado: (2011) -
Role of SDF-1 as a regulatory chemokine in renal regeneration after acute kidney injury
por: Togel, Florian E, et al.
Publicado: (2011) -
The application of resveratrol to mesenchymal stromal cell-based regenerative medicine
por: Hu, Chenxia, et al.
Publicado: (2019) -
Mesenchymal Stromal/Stem Cells in Regenerative Medicine and Tissue Engineering
por: Fitzsimmons, Ross E. B., et al.
Publicado: (2018) -
Mesenchymal stromal cells in the development and therapy of bronchopulmonary dysplasia
por: Möbius, Marius A., et al.
Publicado: (2016)